Konica Minolta and Screen Graphic Solutions (Screen GA) have strengthened their collaboration in the commercial digital printing area. The companies plan to promote hybrid workflows and increase user-friendliness in offset printing and digital printing. Plans also include further enhancement of efficiency, extending business opportunities, and delivering new value in the commercial printing industry. The seamless hybrid workflows will be achieved by improving data exchange between Screen GA's Equios and the Accurio portfolio of Konica Minolta. The companies have improved data exchange in the Job Definition Format between the Equios universal workflow systems and the Accurio inkjet and toner digital presses. The improved data : exchange allows users to directly carry out digital printing from the Equios, achieving seamless operation that features colour management and finishing. The solution increases commercial printing efficiency in a production; environment and provides new business opportunities by taking full advantage of ondemand printing. Screen GA business development division head and corporate officer Toru Kawada said the company has continuously improved the Equios universal workflow systems that combine CTP workflow systems with cutting-edge inkjet printing technologies.
Seiko Epson Co. said it will market 12 new projector models for business and home use. The company has readied seven models for business use and five for home use. For the business use, all the models feature brightness range of 3,200lm to 3600lm, keeping high visibility even in a bright room, and resolution from SVGA to WUXGA. All the models are compact and lightweight – less than 3kg. The top of the line, model EB-U42 features full HD resolution (WUXGA 1920 x 1200) and brightness of 3600lm, carrying a suggested price tag of 132,000 yen. The most affordable model EB-S05 features 3200lm and SVGA (800 x 600) resolution, with suggested price of 44,980 yen. The company targets to sell 150,000 units a year. Epson has readied five models as home projectors in two high-quality lines with 2 models and one basic model. The high-quality lines come with the projector itself as a set, with a projector and screen. All the models feature brightness of up to 2500lm enabling viewing in a bright room. The basic model EB-W05 features WXGA (1280 x 800) resolution and 3300lm, selling under expected price of 64,980 yen. The high-quality models, the EH-TW5650 is equipped with a 1080p panel equivalent to full HD resolution, brightness of 2500lm and contrast ratio of 60,000:1. When using a media streaming device, it can be wirelessly connected with AV equipment. It will be available at an expected price of 129,980 yen (without a screen) and 135,980 yen (with a screen). The EH-TW650/TW650S features full HD resolution, brightness 3100lm and contrast of 15,000:1. Expected selling prices are 99,980 yen and 105,980 yen, respectively.
Japan's leading printer and photocopier maker Konica Minolta Inc. announced at the company will be acquiring Ambry Genetic Corp. - a US diagnostic company, in a deal valued at up to USD 1 billion. This is one of the largest deals for Konica Minolta and the company will jointly carry out the acquisition with the funds provided by Innovation Network Corp of Japan. Konica Minolta, which has a market value of around $4 billion, will account for 60 percent of the investment and the Innovation Network Corp of Japan (INCJ) will provide for the remaining 40 percent. Both the companies intend to enter into the precision medicine segment which is expected to have a great potential for the treatment of cancer. KMI has its own diagnostic technique, utilising a High Sensitive Tissue Testing (HSTT) technology, while Ambry excels in genetic tests for breast, colon and cancers, heart and respiratory diseases, etc. Further, the company will combine its HSTT technology and Ambry's genetic diagnostic technology to offer high-standard cancer diagnostic services and aid the development of new reagents which will help produce new medicines. Talking about the acquisition, Shoei Yamana - Chief Executive Officer of Konica Minolta Inc., said, “Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual's genetic and biochemical makeup." The companies expect to complete the necessary procedure for the deal by the end of October, 2017 and post which, Ambry will become a subsidiary of KMI while Ambry's business will be continued in the US.